Roche: Positive results in phase II for etrolizumab in Ulcerative Colitis

NEUTRAL, Fair Value CHF254 (+3%)

News published on May Monday 20, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities